Skip to main content
Treatment
Outcomes
Safety
Prescribing Flow
Resources
Get started For patients
Treatment
Outcomes
Safety
Prescribing Flow
Resources
Get started For patients
tDCS evidence Overview Webinars In-clinic resources Marketing materials

tDCS evidence

Woodham, R.D., Selvaraj, S., Lajmi, N. et al. | October 2024
A ten-week double-blinded randomised control trial to evaluate the effectiveness and tolerability of the Flow tDCS device with an additional ten-week follow-up
Read study
Griffiths, C., da Silva, K. M., Mobee-Dumi, A., Gill, A. K., & Ibrahim, D. | June 2025
Transcranial Direct Current Stimulation (tDCS) and Online Wellbeing Training Used at Home for Perinatal and Maternal Loss Patients with a Diagnosis of Depression: Depression, Real World-Functioning, and Quality of Life Outcomes
Read study
Silva, K., Griffiths, C., Banazadeh, A. and Mu, M. | April 2025
Transcranial Direct Current Stimulation (tDCS) Used at Home for People with a Diagnosis of Depression: Sleep Quality Outcomes
Read study
Griffiths, C., McIlhiney, W., Evans, A., O'Neill-Kerr, A., et al. | November 2024
Impact of Flow tDCS for Depression Treatment in a Community Mental Health Team Service: Depression, Functioning, and Health-Related Quality of Life Outcomes
Read study
Griffiths, C., Abdalla, S., Mcconnochie, M., Jiang, H. | November 2024
Impact of Self-Administered Flow tDCS Depression Treatment in a Crisis Resolution & Home Treatment Service: Functioning and Health-Related Quality of Life Outcomes
Read study
Griffiths, C., McIlhiney, W., O'Neill-Kerr, A., Walker, K., and Stringer | August 2024
Feasibility and impact review of at-home Flow treatment for CMHT patients
Read study
Griffiths, C., Jiang, H., Smart, D., Zafar, A. | July 2024
Flow tDCS can effectively and efficiently be delivered through a primary healthcare general practice service and patients will choose to use
Read study
Baukaite, E., Noel-Johnson, A., Walker, K., Griffiths, C. | June 2024
Experiences and Value of Flow; Used at Home for Specialist Perinatal Mental Health Service and Maternal Loss Psychology Service Patients with Depression
Read study
Griffiths, C., Maravic da Silva, K., Jiang, H., Smart, D., and Zafar, A. | May 2024
Flow for Depression Treatment in a Primary Healthcare General Practice—Depression, Functioning, and Health-Related Quality of Life Outcomes
Read study
Griffiths, C., Walker, K., Willis, A. | February 2024
Qualitative Study Exploring the Experience and Value of Flow - Community Mental Health
Read study
Griffiths, C., Walker, K., Jiang, H., Noel-Johnson, A. and Zafar, A. | November 2023
Qualitative Study Exploring the Experience and Value of Flow - Primary Care
Read study

Additional studies

showcasing Flow

Woodham et al. | November 2023
Home-based tDCS is a potential first line treatment for MDD that is acceptable and safe
Read study
Sobral et al. | October 2022
Using Flow home-based tDCS in clinical practice; case series
Read study
Woodham et al. | September 2022
Is Flow a potential first line of treatment for depression?
Read study
Rimmer et al. | May 2022
Participants in open-label trial "would very strongly recommend" Flow
Read study
Borrione et al. | April 2021
Open label study showed substantial improvements in 80% of participants
Read study
Borrione et al. | September 2020
Computational modeling of the Flow headset stimulation parameters and montage
Read study

Additional studies

reviewing tDCS

Nikolin et al. | March 2023
tDCS antidepressant effects peak at around 6 weeks
Read study
Frengi et al. | July 2020
tDCS for depression is definitely effective (level A evidence)
Read study
Moffa et al. | April 2020
A meta-analysis: tDCS was an effective intervention in reducing depressive symptoms
Read study
Razza et al. | February 2020
An analysis of 23 clinical trials with 1092 patients, showing that tDCS is superior to placebo/sham
Read study
Chhabra et al. | February 2020
Side effects from tDCS are mild, transient and well-tolerated
Read study
Sharafi et al. | July 2019
tDCS is efficient in cases where antidepressants don't work
Read study
Wang et al. | June 2019
A meta-analysis: the intervention of tDCS was superior to the use of sham tDCS
Read study
Mutz et al. | March 2019
tDCS was found to be efficacious and comparable to TMS
Read study
Pavlova et al. | December 2017
30-minute tDCS sessions lead to better outcomes than 20-minute sessions
Read study
Bikson et al. | October 2017
Low-energy brain stimulation is safe to use
Read study
Brunoni et al. | June 2017
Study including 245 patients, comparing tDCS with a common antidepressant
Read study
Bikson et al. | June 2016
No serious adverse events were found across 33,200 tDCS sessions with 1000 users
Read study
Valiengo et al. | April 2013
tDCS is a safe long-term follow-up treatment
Read study
Brunoni et al. | April 2013
Combining tDCS and a common antidepressant increases the efficacy of each treatment
Read study
Loo et al. | January 2012
tDCS is safe and effective for treating depression
Read study

Overview

Flow Clinician Overview | November 2024
Clinician Overview Guide to Flow Neuroscience
Read more
Who is eligible for Flow? | November 2024
Eligibility Guide to Flow Neuroscience
Read more
Suggested Flow Neuroscience Treatment Pathway | November 2024
Treatment Schedule Guide to support personalised patient care
Read more
Flow patient profiles | September 2024
Collection of patient examples from real-world clinical cases
Read more

Webinars

Deep dive into Neuromodulation

What can 2mA really do?

An exclusive look at how Professor Alex ONeill-Kerr utilises TMS and tDCS.

During this 60min webinar, hear more about his experiences using Flow in his private practice and the following topics: 

  • Key differences between TMS and tDCS
  • Innovative approaches for enhanced patient outcomes
  • Real-world patient examples
  • Open Q&A session

This webinar is intended for educational use only. Also available here.

Play video

Flow in the Private Practice

Hear directly from Dr. Hannah Nearney and Dr. Kultar Garcha as they share their first-hand experiences with integrating Flow Neuroscience into their private practices and patient care strategies.

Delving into topics such as:

  • What aspects of Flow they find most beneficial in their practice
  • Why they have chosen to incorporate Flow into their treatment protocols
  • Patient demographics they have successfully treated with Flow
  • Open Q&A session

This webinar offers invaluable insights into the practical applications of Flow Neuroscience, directly from those who have witnessed its impact in clinical settings. Also available here.

Play video

Contraindications

and side-effects of Flow

Flow Neuroscience's Global Medical Director, Dr. Kultar Garcha, provides an update regarding Flow's contraindications, warnings, and side-effects.

Watch this webinar to learn more on:

  • tDCS side-effects from the literature and clinical trial
  • Flow side-effects from real-world data
  • What's changed with Flow's contraindications and warnings?
2024 Flow Prescribing Information update

Overview of long-term usage

and Flow treatment schedules

Flow Neuroscience's Clinical Lead, Hanna Silva, shares insights about Flow's stimulation schedule and long-term usage.

Specifically:

  • Overview of the Flow treatment schedule
  • What does the evidence say about long-term usage of tDCS?
  • Alternative stimulation schedule recommendations
  • Open Q&A
Play video

In-clinic resources

Patient Getting Started Guide | January 2023
Online guide reviewing what to expect from Day 1 to week 1 to month 1 with Flow
Go to guide
Patient Brochure | June 2024
Everything your patient may need to know in one place
Download brochure
Patient perspective video | January 2023
Annie Lovatt's Story
Go to video
Educational video | January 2023
What is tDCS? An overview look at how and why tDCS works
Go to video

Marketing material

Flow Neuroscience | February 2024
Collection of Flow and patient images available for use
Download zip
Flow Neuroscience logos | February 2024
Collection of Flow logos available for use
Download zip
Get started

Join clinicians transforming depression treatments with Flow

Flow is already in use across NHS Trusts, private clinics, and research sites. Request a demo or speak to a clinician about integrating Flow into your practice.
Get started
Resources
Flow & tDCS Evidence Flow Overview Flow Webinars In-clinic Resources Marketing Materials
About & Support
About Contact us Patient Platform FAQ
For patients
Flow User manual FAQ
Terms and conditions
Privacy policy
Manage cookies
Go to facebook Go to Instagram Go to X Go to Youtube
© 2026 Flow Neuroscience